Model
Edge
RVL Pharmaceuticals
RVLPQ
Filing Type
8-K
Filing Date
10/12/2023
Updated
10/13/23, 10:15 AM
Filing
8-K
Earnings Release
Exhibits
8-K
End of Material Contract, Bankruptcy or Receivership, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
EX-10.1
EXHIBIT 10.1
EX-99.1
End of Material Contract, Bankruptcy or Receivership, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing